Literature DB >> 17606206

Liver transplantation for metabolic liver diseases.

Kristine Y Zhang1, Bruce Y Tung, Kris V Kowdley.   

Abstract

Liver transplantation has become an accepted treatment for several metabolic liver diseases. With advances in organ transplantation and immunosuppressive strategies, survival rates following liver transplantation are generally excellent. When the primary metabolic defect is hepatic in origin, liver transplantation not only replaces the dysfunctional organ but also cures the underlying metabolic defect. For conditions in which the primary metabolic defect is extrahepatic, liver transplantation is usually performed for hepatic complications, although disease recurrence may occur. This article reviews common metabolic liver diseases treated with liver transplantation in the adult population.

Entities:  

Mesh:

Year:  2007        PMID: 17606206     DOI: 10.1016/j.cld.2007.04.002

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  3 in total

1.  Prevalence of liver disease in Colombia between 2009 and 2016.

Authors:  Diana Fernanda Bejarano Ramírez; Gabriel Carrasquilla Gutiérrez; Alexandra Porras Ramírez; Alonso Vera Torres
Journal:  JGH Open       Date:  2020-02-19

Review 2.  Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects.

Authors:  Kara R Vogel; Andrew A Kennedy; Luke A Whitehouse; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2013-10-02       Impact factor: 4.982

3.  National trends and outcomes of genetically inherited non-alcoholic chronic liver disease in the USA: estimates from the National Inpatient Sample (NIS) database.

Authors:  Eric M Sieloff; Brian Rutledge; Cuyler Huffman; Duncan Vos; Thomas Melgar
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.